Chongqing Pharscin Pharmaceutical Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100003308
CNY
13.70
0.09 (0.66%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
813.88
762.71
680.53
772.84
834.56
872.66
835.05
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
813.88
762.71
680.53
772.84
834.56
872.66
835.05
Raw Material Cost
387.62
360.60
336.66
332.77
412.29
468.65
320.21
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
102.87
103.78
105.79
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.04
0.03
1.01
14.44
18.25
17.23
9.22
Selling and Distribution Expenses
293.86
288.11
244.25
282.40
284.98
257.82
321.34
Other Expenses
7.98
5.14
6.98
4.44
-7.94
-8.45
-8.94
Total Expenditure (Excl Depreciation)
761.31
700.18
651.75
673.99
738.99
762.95
667.10
Operating Profit (PBDIT) excl Other Income
52.599999999999994
62.5
28.799999999999997
98.9
95.60000000000001
109.7
168
Other Income
17.84
30.90
19.08
28.58
29.53
44.48
37.68
Operating Profit (PBDIT)
158.93
179.14
129.58
198.91
191.87
200.97
228.99
Interest
0.04
0.03
1.01
14.44
18.25
17.23
9.22
Exceptional Items
9.65
7.56
3.52
1.57
1.09
1.25
1.95
Gross Profit (PBDT)
426.26
402.11
343.87
440.07
422.27
404.00
514.84
Depreciation
88.91
86.10
81.19
72.65
67.33
47.32
23.74
Profit Before Tax
79.62
100.57
50.89
113.39
107.38
137.67
197.99
Tax
22.25
16.71
10.10
9.84
11.64
17.86
28.25
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
65.09
76.73
32.70
98.40
91.78
119.19
169.75
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
65.09
76.73
32.70
98.40
91.78
119.19
169.75
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-9.88
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
55.21
76.73
32.70
98.40
91.78
119.19
169.75
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,691.32
1,660.00
1,617.92
1,610.39
1,183.59
1,099.47
1,070.80
Earnings per share (EPS)
0.16
0.18
0.08
0.24
0.23
0.3
0.42
Diluted Earnings per share
0.16
0.18
0.08
0.24
0.23
0.3
0.42
Operating Profit Margin (Excl OI)
6.41%
8.15%
4.31%
12.64%
11.38%
12.51%
20.07%
Gross Profit Margin
20.71%
24.47%
19.41%
24.07%
20.93%
21.2%
26.55%
PAT Margin
8.0%
10.06%
4.8%
12.73%
11.0%
13.66%
20.33%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 6.71% vs 12.08% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is -28.03% vs 134.56% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is -4.79% vs 34.12% in Dec 2024

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has fallen from Dec 2024

Compare Annual Results Of Chongqing Pharscin Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
813.88
0
813.88
Other Operating Income
0.00
0.00
0.00
Total Operating income
813.88
0
813.88
Raw Material Cost
387.62
0
387.62
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.04
0
0.04
Selling and Distribution Expenses
293.86
0
293.86
Other Expenses
7.98
0.00
7.98
Total Expenditure (Excl Depreciation)
761.31
0
761.31
Operating Profit (PBDIT) excl Other Income
52.57
0.00
52.57
Other Income
17.84
0
17.84
Operating Profit (PBDIT)
158.93
0
158.93
Interest
0.04
0
0.04
Exceptional Items
9.65
0
9.65
Gross Profit (PBDT)
426.26
0
426.26
Depreciation
88.91
0
88.91
Profit Before Tax
79.62
0
79.62
Tax
22.25
0
22.25
Provisions and contingencies
0
0
0.00
Profit After Tax
65.09
0
65.09
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
65.09
0
65.09
Share in Profit of Associates
0
0
0.00
Minority Interest
-9.88
0
-9.88
Other related items
0.00
0.00
0.00
Consolidated Net Profit
55.21
0
55.21
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,691.32
0
1,691.32
Earnings per share (EPS)
0.16
0
0.16
Diluted Earnings per share
0.16
0
0.16
Operating Profit Margin (Excl OI)
6.41%
0%
0.00
6.41%
Gross Profit Margin
20.71%
0%
0.00
20.71%
PAT Margin
8.00%
0%
0.00
8.00%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 81.39 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 6.71% vs 12.08% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 5.52 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -28.03% vs 134.56% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 14.11 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -4.79% vs 34.12% in Dec 2024

Annual - Interest
Markets Mojo
No Interest in the last few periods
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 6.41%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has fallen from Dec 2024